Clinical trial
Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia…
NCT00413972 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00413972 |
|---|---|
| Title | Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420) |
| Official title | A Multicenter, Double-blind, Randomized, Placebo-controlled Parallel Groups Study Comparing the Efficacy and Safety of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia |
| Lead sponsor | Organon and Co, Industry |
| Collaborators | Schering-Plough Industry Merck Sharp & Dohme LLC |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | ezetimibe with simvastatin, Ezetimibe with Simvastatin, Placebo |
| Enrollment | 392 |
| Start date | Apr 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Dec 20, 2006 |
| Last update posted | Feb 9, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: